Yamamoto K, Kimura K, Hanawa S, Katagiri I, Fujimura Y, Tani C, Ouchi T, Sato S, Ogiso M
Nihon Geka Gakkai Zasshi. 1984 Sep;85(9):1072-5.
In treating advanced carcinoma of the rectum, we have actively used radiotherapy as an adjunct to surgery to enlarge the group of patients indicating surgery and improve the remote results. Of total 423 patients with rectal cancer treated by us in the past 16 years, 202 patients (47.8%) received radiotherapy. Preoperative radiotherapy was performed on 90 of these patients, postoperative radiotherapy on 73 patients, preoperative plus postoperative radiotherapy on 15 patients, and radiotherapy alone on 24 patients. The present study is mainly concerned with preoperative radiotherapy. The purpose of preoperative radiotherapy is to increase the number of patients suitable for surgery. We selected Dukes-C cases without distant metastasis as indications for preoperative radiotherapy, and treated them by 2-step irradiation with 3,000-6,000 rads using Linac after 2 weeks of preoperative observation. The gross and histologic evaluation of the results of irradiation permitted us to conclude that over 3,000 rads was necessary for preoperative radiotherapy. Comparison of the results between preoperative radiotherapy and control groups showed that local recurrence occurred in 6.7% of the radiotherapy group and 9.0% of the control, and 5-year-survival rate was 62.7% and 53.2% respectively, with prognosis improved in the radiotherapy group.
在治疗晚期直肠癌时,我们积极采用放疗作为手术的辅助手段,以扩大适合手术的患者群体并改善远期疗效。在过去16年里我们治疗的423例直肠癌患者中,202例(47.8%)接受了放疗。其中90例患者接受了术前放疗,73例接受了术后放疗,15例接受了术前加术后放疗,24例仅接受了放疗。本研究主要关注术前放疗。术前放疗的目的是增加适合手术的患者数量。我们选择无远处转移的Dukes-C期病例作为术前放疗的适应证,并在术前观察2周后,使用直线加速器分两步给予3000 - 6000拉德的照射剂量进行治疗。对放疗结果的大体和组织学评估使我们得出结论,术前放疗需要超过3000拉德的剂量。术前放疗组与对照组结果的比较显示,放疗组局部复发率为6.7%,对照组为9.0%,5年生存率分别为62.7%和53.2%,放疗组预后得到改善。